The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer
Clinical trial NCT07460180 · RECRUITING
Trial details
- NCT number
- NCT07460180
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.